TickerFacts.

YD Bio Ltd (YDES): Total Liabilities

Annual figures by period end, from SEC filings.

$16.64M
As of 2025-12-31
2024-12-31: $274.0K2025-12-31: $16.64M$16.64M
2024-12-31 Total Liabilities (USD) 2025-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2025-12-31$16.64Mn/m2026-04-30, Balance as of period end
2024-12-31$274.0Kn/a2026-04-30, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
YD Bio Ltd (YDES)2025-12-31$16.64Mn/m
Sera Prognostics, Inc. (SERA)2025-12-31$26.52M+7.1%
Aclarion, Inc. (ACON)2025-12-31$837.3K-27.4%
BioNexus Gene Lab Corp (BGLC)2025-12-31$637.9K-69.8%
American Shared Hospital Services (AMS)2025-12-31$27.79M-7.9%
CapForce Inc. (CFOR)2025-12-31$6.20M+149.7%
Exagen Inc. (XGN)2025-12-31$40.57M+15.4%
Personalis, Inc. (PSNL)2025-12-31$72.98M+8.4%
Biodesix Inc (BDSX)2025-12-31$89.94M+17.8%

Compare YDES, SERA, ACON, BGLC side by side · Screen every company in Services-Medical Laboratories ↗